Nektar Therapeutics Dividend
Dividend criteria checks 0/6
Nektar Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.3% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$1.50 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
There's No Escaping Nektar Therapeutics' (NASDAQ:NKTR) Muted Revenues Despite A 44% Share Price Rise
Feb 15Nektar Therapeutics' (NASDAQ:NKTR) Business And Shares Still Trailing The Industry
Dec 31Is Nektar Therapeutics (NASDAQ:NKTR) In A Good Position To Invest In Growth?
Nov 06Is Nektar Therapeutics (NASDAQ:NKTR) In A Good Position To Invest In Growth?
Apr 24Here's Why Nektar Therapeutics (NASDAQ:NKTR) Must Use Its Cash Wisely
Jan 24Is Nektar Therapeutics (NASDAQ:NKTR) In A Good Position To Deliver On Growth Plans?
Aug 19Nektar: Time To Abandon Ship
Jul 17Nektar promotes internal executive to CFO role
Jul 01We Think Nektar Therapeutics (NASDAQ:NKTR) Needs To Drive Business Growth Carefully
May 11After A High-Profile Failure In Melanoma, Nektar Therapeutics' Value Shifts To Its Early-Stage Pipeline
Apr 04Analysts Just Made A Major Revision To Their Nektar Therapeutics (NASDAQ:NKTR) Revenue Forecasts
Mar 09Nektar Therapeutics: Beaten Down By 2020
Jan 26We Think Nektar Therapeutics (NASDAQ:NKTR) Can Easily Afford To Drive Business Growth
Jan 13Nektar Therapeutics (NASDAQ:NKTR) Analysts Just Trimmed Their Revenue Forecasts By 11%
Dec 09Nektar Therapeutics (NASDAQ:NKTR) Is In A Strong Position To Grow Its Business
Oct 05Nektar Therapeutics' Short Covering Surges By 200% In 2 Weeks
Sep 29Nektar Sends Shot Across Bristol Myers Squibb's Bow With Big Pfizer Collaboration
Sep 23Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if NKTR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NKTR's dividend payments have been increasing.
Dividend Yield vs Market
Nektar Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (NKTR) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Pharmaceuticals) | 2.3% |
Analyst forecast in 3 Years (NKTR) | 0% |
Notable Dividend: Unable to evaluate NKTR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NKTR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate NKTR's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as NKTR has not reported any payouts.